CoChat

Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND OBJECTIVES: Brain-computer interfaces (BCIs) are being developed to restore mobility, communication, and functional independence to people with paralysis. Though supported by decades of preclinical data, the safety of chronically implanted microelectrode array BCIs in humans is unknown. We report safety results from the prospective, open-label, nonrandomized BrainGate feasibility study (NCT00912041), the largest and longest-running clinical trial of an implanted BCI. METHODS: Adults aged 18-75 years with quadriparesis from spinal cord injury, brainstem stroke, or motor neuron disease were enrolled through 7 clinical sites in the United States. Participants underwent surgical implantation of 1 or 2 microelectrode arrays in the motor cortex of the dominant cerebral hemisphere. The primary safety outcome was device-related serious adverse events (SAEs) requiring device explantation or resulting in death or permanently increased disability during the 1-year postimplant evaluation period. The secondary outcomes included the type and frequency of other adverse events and the feasibility of the BrainGate system for controlling a computer or other assistive technologies. RESULTS: From 2004 to 2021, 14 adults enrolled in the BrainGate trial had devices surgically implanted. The average duration of device implantation was 872 days, yielding 12,203 days of safety experience. There were 68 device-related adverse events, including 6 device-related SAEs. The most common device-related adverse event was skin irritation around the percutaneous pedestal. There were no safety events that required device explantation, no unanticipated adverse device events, no intracranial infections, and no participant deaths or adverse events resulting in permanently increased disability related to the investigational device. DISCUSSION: The BrainGate Neural Interface system has a safety record comparable with other chronically implanted medical devices. Given rapid recent advances in this technology and continued performance gains, these data suggest a favorable risk/benefit ratio in appropriately selected individuals to support ongoing research and development. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov Identifier: NCT00912041. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that the neurosurgically placed BrainGate Neural Interface system is associated with a low rate of SAEs defined as those requiring device explantation, resulting in death, or resulting in permanently increased disability during the 1-year postimplant period.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000201707

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure Components of the Investigational BrainGate Neural Interface System (A) The recording sensor is a “Utah” microelectrode array (NeuroPort, prior manufacturer: Cyberkinetics Neurotechnology Systems; present manufacturer, Blackrock Neurotech; both, Salt Lake City, UT) consisting of 96 electrodes arranged on a 4 × 4-mm platform. During surgical placement, the microelectrode array is placed onto the cortical surface of the predetermined brain region of interest and a pneumatic inserter wand is used to apply a precise amount of force to the array, inserting the microelectrodes through the pial surface and into the upper layers of cortex. (B) The microelectrode array is connected through a bundle of gold wires to a percutaneous pedestal, which is affixed to the outer table of the cranium by titanium surgical screws. When not in use, the percutaneous pedestal is covered by a disposable fitted cap. (C) Signals from the pedestal are transmitted either wirelessly10 or through a cable to a signal processor, decoding computers, and output devices. Images published with permission from the authors.
Figure Components of the Investigational BrainGate Neural Interface System (A) The recording sensor is a “Utah” microelectrode array (NeuroPort, prior manufacturer: Cyberkinetics Neurotechnology Systems; present manufacturer, Blackrock Neurotech; both, Salt Lake City, UT) consisting of 96 electrodes arranged on a 4 × 4-mm platform. During surgical placement, the microelectrode array is placed onto the cortical surface of the predetermined brain region of interest and a pneumatic inserter wand is used to apply a precise amount of force to the array, inserting the microelectrodes through the pial surface and into the upper layers of cortex. (B) The microelectrode array is connected through a bundle of gold wires to a percutaneous pedestal, which is affixed to the outer table of the cranium by titanium surgical screws. When not in use, the percutaneous pedestal is covered by a disposable fitted cap. (C) Signals from the pedestal are transmitted either wirelessly10 or through a cable to a signal processor, decoding computers, and output devices. Images published with permission from the authors.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Hochberg LR, Anderson K. BCI users and their needs. In: Wolpaw JR, Wolpaw E, eds. Brain-Computer Interfaces: Principles and Practice Hardcover. Oxford University Press; 2012.

Cited by

See all 81

Metadata

Authors
Rubin, D. B., Ajiboye, A. B., Barefoot, L., Bowker, M., Cash, S. S., Chen, D., Donoghue, J. P., Eskandar, E. N., Friehs, G., Grant, C., Henderson, J. M., Kirsch, R. F., Marujo, R., Masood, M., Mernoff, S. T., Miller, J. P., Mukand, J. A., Penn, R. D., Shefner, J., Shenoy, K. V., Simeral, J. D., Sweet, J. A., Walter, B. L., Williams, Z. M., & Hochberg, L. R.
Affiliations
  • Harvard University (US)
  • Shirley Ryan AbilityLab (US)
  • Albert Einstein College of Medicine (US)
  • Barrow Neurological Institute (US)
  • Cleveland Clinic (US)
Corresponding author
Rubin, Daniel B.
Venue
Neurology
Published
2023-03-14
Volume
100
Issue
11
Pages
e1177-e1192
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W4316020459
Cited by
81
References
48
Citations by year
2026: 24 · 2025: 25 · 2024: 24 · 2023: 8
FWCI
9.80
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • U.S. Department of Veterans Affairs (IK6 RX004284, I01 RX002295, I50RX002864, B6453-R, N9228C, B6459L, N-2864-C)
  • American Heart Association (19CSLOI34780000)
  • Massachusetts General Hospital
  • Brown University
  • Harvard Catalyst
  • Case Western Reserve University
  • National Institutes of Health (n01hd53403-6-0-1, N01HD10018, 5uh2ns095548-02, 5u01dc017844-06)
  • U.S. Food and Drug Administration
  • Wu Tsai Neurosciences Institute, Stanford University
  • Office of Naval Research (N00014)
  • National Institute on Deafness and Other Communication Disorders (R01DC009899, R01DC014034, U01- DC017844)
  • National Institute of Neurological Disorders and Stroke (R01NS062092, UH2-NS095548, U01NS098968, UE5NS065743, R25NS065743)
  • National Institute of Biomedical Imaging and Bioengineering (T32EB004314)
  • National Institute of Child Health and Human Development
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (N01-HD-53403, R01HD077220, N01HD10018)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
  • Life Sciences › Neuroscience › Cognitive Neuroscience › EEG and Brain-Computer Interfaces
  • Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
Keywords
brain-computer interface, chronic implantation, microelectrode arrays, motor cortex, device-related adverse events, device explantation, tetraparesis, spinal cord injury, brainstem infarction, motor neuron disease, assistive technology, risk-benefit assessment
MeSH terms
Adult, Feasibility Studies, Humans, Prospective Studies, Quadriplegia, Spinal Cord Injuries, Brain-Computer Interfaces

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System. https://app.cochat.ai/papers/10.1212/wnl.0000000000201707
The paper
Rubin, D. B., Ajiboye, A. B., Barefoot, L., Bowker, M., Cash, S. S., Chen, D., Donoghue, J. P., Eskandar, E. N., Friehs, G., Grant, C., Henderson, J. M., Kirsch, R. F., Marujo, R., Masood, M., Mernoff, S. T., Miller, J. P., Mukand, J. A., Penn, R. D., Shefner, J., . . . Hochberg, L. R. (2023). Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System. Neurology. https://doi.org/10.1212/wnl.0000000000201707

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.